NEUTRISCI ANNOUNCES INITIAL ORDER FROM CRYOPHARM

VANCOUVER, British Columbia, June 19, 2019 (GLOBE NEWSWIRE) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the [...]

NEUTRISCI ANNOUNCES EXCLUSIVE DISTRIBUTION DEAL

VANCOUVER, British Columbia, May 02, 2019 (GLOBE NEWSWIRE) – NeutriSci International Inc. (“NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind [...]

NEUTRISCI ENTERS INTO LOI WITH FALCON TECHNOLOGIES INC. dba ECOGROWTH STRATEGIES TO MANUFACTURE SUBLINGUAL CBD PRODUCTS

– Signing of definitive agreement expected in early Q2 – First orders expected in early Q3 Vancouver, British Columbia – March 25, 2019 – Neutrisci International Inc. (the [...]

NEUTRISCI AND NATURALLY SPLENDID USA ANNOUNCE EXPANDED BINDING TERMS OF PARTNERSHIP AND ADDED DISTRIBUTION OF HEMPOMEGA™ AND CANNABIDIOL (CBD) SUBLINGUAL TABLETS

Vancouver, British Columbia – October 11, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to [...]

NEUTRISCI COMPLETES PRIVATE PLACEMENT

VANCOUVER, British Columbia – October 5, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) is pleased to [...]

NEUTRISCI TO COMPLETE SHARE SETTLEMENT

Vancouver, British Columbia – March 27, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI FILES PATENT APPLICATION

Vancouver, British Columbia – March 1, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]

NEUTRISCI AND LEXARIA BIOSCIENCE ENTER GLOBAL LICENSING AGREEMENT

Vancouver, British Columbia – February 26th, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) and Lexaria [...]

NEUTRISCI NAMED TO THE 2018 TSX VENTURE 50®

  VANCOUVER, B.C. – Feb. 22, 2018 (GLOBE NEWSWIRE) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) [...]

NEUTRISCI ANNOUNCES A MAJOR R&D MOU WITH SCIENTUS PHARMA TO DEVELOP A MEDICAL CANNABINOID RETAIL PRODUCT

Vancouver, British Columbia – January 8, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and [...]

page 1 of 2